Avaleht/Aktsiad/AGEN

AGEN

USD

Agenus Inc. Common Stock

$3.980+0.140 (3.646%)

Reaalajas hind

Healthcare

Biotehnoloogia

Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$3.840

Kõrge

$3.980

Madal

$3.700

Maht

0.33M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

126.8M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.46M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $1.38Praegune $3.980Kõrge $7.34

Seotud uudised

10. sept 2025 · 10:49

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus with a Buy and maintains $23 price target.

Vaata rohkem

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target

9. sept 2025 · 11:43

BusinessWire

France Grants Reimbursed Compassionate Access (AAC) for Agenus' BOT/BAL in Refractory MSS Metastatic Colorectal Cancer

Agenus Inc. (NASDAQ:AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory microsatellite‑stable

Vaata rohkem

$France Grants Reimbursed Compassionate Access (AAC) for Agenus' BOT/BAL in Refractory MSS Metastatic Colorectal Cancer$

28. aug 2025 · 18:04

Earnings Call Transcripts

Agenus Inc. (AGEN) Virtual Stakeholder Briefing Call (Transcript)

Vaata rohkem

28. aug 2025 · 14:44

PR Newswire

FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone

Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with...

Vaata rohkem

FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone

28. aug 2025 · 10:50

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus with a Buy and maintains $23 price target.

Vaata rohkem

BusinessWire

26. aug 2025 · 13:37

Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight

Webcast details updated from the August 11th release Webcast on Wednesday, August 27, 2025 at 4:00 p.m. EST Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in immuno-oncology, today announced an update to its